Finally, ALDH+ and CD29hi CD61+ BCSCs depleted of BGN exhibited reduced metastasis, suggesting BGN as a potential therapeutic target in BCSCs to inhibit breast cancer metastasis. The gene discussed is ITGB3; the disease is breast carcinoma.